---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-003501"
form_type: "8-K"
ticker: null
cik: "0001460602"
company_name: "Orgenesis Inc."
filed_at: "2026-01-26T23:59:59+00:00"
generated_at: "2026-05-16T07:54:10.983529+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Orgenesis issues warrant for 3.29M shares under $1M loan drawdown

## Summary
- Issued Alpha Warrant for 3,289,490 common shares at $250,000 aggregate exercise price.
- Warrant is exercisable for three years from January 9, 2026.
- Part of a $1M drawdown under the September 2025 Convertible Loan Agreement with Alpha Prosperity Fund SPC.
- Shares issuable upon exercise are unregistered, exempt under Section 4(a)(2) of the Securities Act.

## SEC filing metadata
- accession: 0001493152-26-003501
- form_type: 8-K
- cik: 0001460602
- company_name: Orgenesis Inc.
- filed_at: 2026-01-26T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1460602/000149315226003501/0001493152-26-003501-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1460602/000149315226003501/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-003501
- JSON: https://secwatch.observer/filing/0001493152-26-003501.json
- Plain text: https://secwatch.observer/filing/0001493152-26-003501.txt

## Key facts
- Material Agreements
  Orgenesis Inc. entered into Convertible Loan Agreement with Alpha Prosperity Fund SPC, acting on behalf of and for the account of Segregated Portfolio P valued at $1,000,000 convertible loan, a $10,000,000 credit facility (effective 2025-09-10).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: Alpha Prosperity Fund SPC, acting on behalf of and for the account of Segregated Portfolio P
  - Value: $1,000,000 convertible loan, a $10,000,000 credit facility
  - Effective: 2025-09-10
  source text: Orgenesis Inc. (the “Company”) entered into that certain Convertible Loan Agreement, dated September 10, 2025, by and among Theracell Laboratories IKE, the Company and Alpha Prosperity Fund SPC, acting on behalf of and for the account of Segregated Portfolio P (the “Lender”) with respect to a $1,000,000 convertible loan, a $10,000,000 credit facility
  evidence_url: https://www.sec.gov/Archives/edgar/data/1460602/000149315226003501/0001493152-26-003501-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.